The development of new orthobiologic treatments and the smooth integration of AI are top accomplishments for these two orthopedic surgeons. Michael Stone, MD, and Bob Yin, MD, recently connected with ...
Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab.
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of ...
Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (Orbit) or bisphosphonates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback